Coloplast A/S (LON:0QBO)
636.21
+2.58 (0.41%)
At close: Jun 11, 2025
Coloplast Revenue
Coloplast had revenue of 6.93B DKK in the quarter ending March 31, 2025, with 5.22% growth. This brings the company's revenue in the last twelve months to 27.79B, up 8.89% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.79B DKK
Revenue Growth
+8.89%
P/S Ratio
5.27
Revenue / Employee
1.67M DKK
Employees
16,639
Market Cap
16.44B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
HSBC Holdings | 44.89B |
AstraZeneca | 42.56B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |